Transient visual field loss after COVID-19 vaccination: Experienced by ophthalmologist, case report

American Journal of Ophthalmology Case Reports

Somboon Panyakorn¹  Worapot Srimanan²  Chaisiri Jumroendararasame³  Kun Tipparut³  Rittirak Othong³  Auraya Jumroendararasame⁴ 

[1] Corresponding author. Department of Ophthalmology, Phramongkutklao hospital 315 Ratchavithi road, Thungphayathai sub-district, Ratchadevhi district, Bangkok, 10400, Thailand.;Department of Ophthalmology, Bangkok Metropolitan Administration General Hospital, Bangkok, Thailand;Department of Ophthalmology, Phramongkutklao Hospital, Bangkok, Thailand;Medical Toxicology Unit, Department of Emergency Medicine, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Bangkok, Thailand;

关键词: Visual field defect;    COVID-19 vaccine;    CoronaVac;    Sinovac;    Case report;   

DOI  :  

来源: DOAJ

【 摘 要 】

Purpose: The first reported case of bilateral transient visual field defect, experienced by an ophthalmologist, which developed shortly after COVID-19 vaccination (CoronaVac, Sinovac Biotech Ltd., Beijing, China) and confirmed by computerized automated perimetry. Observation: The patient is a 42-year-old Thai ophthalmologist. He developed blurred vision within an hour after the second dose of COVID-19 vaccination. We described his self-observed of sequential symptoms, chronologic events, and management steps. The visual field of left congruous hemianopia with respect to vertical midline was detected with computerized automated perimetry. The possible mechanism could be related to an acute vasospasm of the artery in the postchiasmatic visual pathway, triggered by COVID-19 vaccine, Corona Vac. Conclusion and importance: With increasing use of the COVID-19 vaccine in the near future, it would be prudent for medical staff and ophthalmologists to be considered and aware of this associated condition.

【 授权许可】

Unknown